Albendazole
Treatment for Cysticercosis
Typical Dosage: 15 mg/kg/day (max 800 mg/day)
Effectiveness
85%
Safety Score
68%
Clinical Trials
10
Participants
10K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
68
DangerousModerateSafe
Treatment Details
Dosage Range
15 mg/kg/day (max 800 mg/day)
Time to Effect
1-2 months for cyst resolution
Treatment Duration
7-28 days
Evidence Quality
HIGHNumber Needed to Treat (NNT)
3(Treat 3 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
100(Treat 100 patients to see 1 additional serious adverse event)
Confidence Score
88%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$50
Monitoring:$1,500
Side Effect Mgmt:$200
Total Annual:$1,750
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
1.5
Outcome-Based Costs
Cost per Responder
$2,187.5
Cost per Remission
$2,500
Albendazole Outcomes
for Cysticercosis
Efficacy Outcomes
Overall Effectiveness
+85%
Response Rate
+80%
Remission Rate
+70%
Common Side Effects
Headache
+18%
Nausea/Vomiting
+8%
Abdominal Pain
+7%
Dizziness
+7%
Elevated Liver Enzymes
+10%
Rash
+3%
Sources:
Active Clinical Trials
2 active trials recruiting for Albendazole in Cysticercosis
Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal Neurocysticercosis
NCT06376396NOT YET RECRUITINGPHASE4
300 participants
INTERVENTIONAL
Started: Jun 1, 2024
Oxfendazole in Mild Parenchymal Brain Cysticercosis
NCT06565507NOT YET RECRUITINGPHASE2, PHASE3
544 participants
INTERVENTIONAL
Started: Dec 15, 2024
Completed Clinical Trials
5 completed trials for Albendazole in Cysticercosis
A Pilot Study of Neurocysticercosis Treatment
NCT00283699COMPLETEDPHASE3
178 participants
INTERVENTIONAL
Cuenca, Ecuador +4 more
Started: Feb 1, 2001
Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis
NCT00004403COMPLETEDNA
120 participants
INTERVENTIONAL
Started: May 1, 2000
Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients
NCT00290823COMPLETEDPHASE3
110 participants
INTERVENTIONAL
Lima, Peru
Started: Apr 1, 2006
Effects of 2 Different Duration of Albendazole Therapy in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CT
NCT02243644COMPLETEDPHASE3
97 participants
INTERVENTIONAL
New Delhi, India
Started: Mar 1, 2014
Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ)
NCT00441285COMPLETEDPHASE2, PHASE3
156 participants
INTERVENTIONAL
Lima, Peru +4 more
Started: Jan 1, 2010